Halia Therapeutics is planning to start two Phase II trials evaluating its lead ...
Janssen’s bispecific antibody received conditional approval as a subcutaneous th...
The functional service provider model can reduce overheads for biopharmaceutical...
The FDA on Monday approved a Pfizer vaccine that aims to protect newborns agains...
Over the weekend, Intellia sought to address concerns in the gene editing commun...
The FDA approved a high-dose version of Regeneron Pharmaceuticals' blockbuster e...
Why did wider adoption of hospital-at-home hospital strategies have to wait for ...
Kellogg’s is desperate to save Tony the Tiger and Toucan Sam from Mexico’s healt...
Payers are reeling as they try to figure out how to sustainably cover new obesit...
Prior to the transplant, dealing with constant eye pain and loss of vision, the ...
A U.S. appeals court struck down key parts of an Oklahoma law designed to regula...
A combination of strict eligibility criteria and special requirements for insura...
With its future in doubt, ProMED, the financially strapped infectious diseases s...
“We like being included. One of my love languages or manifestations of my love l...
The often-irreversible damage experienced by physicians and medical students who...
Astellas Pharma has announced that EMA has accepted the MAA from its subsidiary ...
